Emily A. Blumberg

Background The COVID‐19 pandemic presented a significant challenge for Organ Procurement Organizations (OPOs) with the use of SARS‐CoV‐2 positive donors varying widely. This study used detailed single OPO data to determine the success of using SARS‐CoV‐2 positive donors. Methods We performed a retrospective cohort study including all SARS‐CoV‐2 positive donors referred to the Gift of Life OPO from January 1, 2021, to June 30, 2023. Descriptive analyses were performed to characterize referral and organ utilization. Results There were 861 organ referrals with 1 positive SARS‐Cov‐2 test: 282 were ruled out with telephone evaluation, 431 referrals were ruled out with onsite evaluation (“evaluated nondonors”) and 148 became donors. For donors who had both nasopharyngeal and lower respiratory testing completed, there was notable result discordance observed. Median cycle threshold (Ct) values were similar between donors and evaluated nondonors with no change in median donor Ct values over the study period. Transplanted organs from COVID‐positive donors included 27 hearts, 88 livers, 5 pancreata, and 107 kidneys; no lung donation occurred. The proportion of COVID‐positive donors significantly increased over the study period. Conclusion This large volume donor referral study demonstrates increasing COVID‐19 referrals progressing to donation over time, supporting the increased use of these donors for nonlung transplantation. image